First Foundation Advisors Sells 661 Shares of Colgate-Palmolive (NYSE:CL)

First Foundation Advisors trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 40.7% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 965 shares of the company’s stock after selling 661 shares during the period. First Foundation Advisors’ holdings in Colgate-Palmolive were worth $94,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Main Street Research LLC raised its holdings in shares of Colgate-Palmolive by 1.5% during the 2nd quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after buying an additional 100 shares in the last quarter. Advisor OS LLC grew its position in Colgate-Palmolive by 4.5% during the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after acquiring an additional 101 shares during the last quarter. BLB&B Advisors LLC grew its position in Colgate-Palmolive by 2.5% during the 2nd quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock worth $421,000 after acquiring an additional 104 shares during the last quarter. ZWJ Investment Counsel Inc. grew its position in Colgate-Palmolive by 3.1% during the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock worth $349,000 after acquiring an additional 109 shares during the last quarter. Finally, Hexagon Capital Partners LLC grew its position in Colgate-Palmolive by 9.5% during the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock worth $124,000 after acquiring an additional 110 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on CL. Morgan Stanley raised their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Stifel Nicolaus lifted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, July 22nd. Barclays lifted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Finally, Sanford C. Bernstein lifted their price objective on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. Nine equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus price target of $102.63.

Colgate-Palmolive Stock Down 0.3 %

Shares of NYSE:CL opened at $106.84 on Wednesday. The stock has a fifty day simple moving average of $101.52 and a two-hundred day simple moving average of $94.88. The stock has a market capitalization of $87.30 billion, a price-to-earnings ratio of 33.81, a PEG ratio of 3.78 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $109.30. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.77 earnings per share. On average, research analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date was Friday, July 19th. Colgate-Palmolive’s payout ratio is 63.29%.

Insider Transactions at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the completion of the transaction, the executive vice president now owns 10,377 shares in the company, valued at $1,069,868.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock worth $4,486,063 over the last quarter. 0.34% of the stock is currently owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.